ATLAS fair value
CHF 23.19
Below fair value · 55% discount
medmix stock price today, ATLAS forecast and fair value
Industrials · Specialty Industrial Machinery · SIX Swiss Exchange · Switzerland
Prices as of Oct 27, 2026 · CHF
CHF 23.19
Below fair value · 55% discount
51%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates medmix's fair value at about CHF 23.19 per share (reasonable range: CHF 13.25 to CHF 33.22). At CHF 10.46, the stock trades 55% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives medmix a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 10.00 and CHF 11.00; in 9 out of 10, between CHF 9.18 and CHF 11.98. Estimated annual volatility is 25%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. medmix sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MEDX.SW has traded between CHF 7.61 and CHF 12.36. Today it is 15.4% below that high and 37% above its low.
Its beta is 0.77: it tends to move less than the market.
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments.
Want to see everything about medmix?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About CHF 23.19 per share according to ATLAS (reasonable range: CHF 13.25 to CHF 33.22). With the stock at CHF 10.46, it is 55% below it.
51%: close to a coin flip. In half of the simulated outcomes, MEDX.SW ends the month between CHF 10.00 and CHF 11.00.
medmix's market capitalization is CHF 416M. We do not show a P/E because it has no positive earnings to base one on.
Yes. MEDX.SW's current dividend yield is 0.97% at today's price (CHF 10.46).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy